While previous h2 estimates of T2D and related clinical traits (e.g., fasting glucose, fasting insulin) have varied between 25% and 80%, they have either excluded or underrepresented individuals of non-European ancestry, particularly African Americans (AAs)2,18–22. This evidence concerns the gene INS and type 2 diabetes mellitus.